| Adaptimmune Therapeutics plc. (7/25/19). "Press Release: Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS". Philadeliphia, PA & Oxfordshire. |
2019-07-25 |
| Adaptimmune Therapeutics plc. (7/22/19). "Press Release: Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center". Philadeliphia, PA & Oxfordshire. |
2019-07-22 |
| Adaptimmune Therapeutics plc. (7/18/19). "Press Release: Adaptimmune Starts the SURPASS Clinical Trial with Its First Next-Generation SPEAR T-cells Targeting MAGE-A4 to Enhance Antitumor Responses". Philadeliphia, PA & Oxfordshire. |
2019-07-18 |
| Adaptimmune Therapeutics plc. (6/27/19). "Press Release: Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer". Philadeliphia, PA & Oxfordshire. |
2019-06-27 |
| Adaptimmune Therapeutics plc. (5/25/17). "Press Release: Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting NY-ESO in Combination with Keytruda (pembrolizumab) in Multiple Myeloma". Philadeliphia, PA & Oxford. |
2017-05-25 |
| Adaptimmune Therapeutics plc. (5/2/17). "Press Release: Adaptimmune to Present at Upcoming Deutsche Bank 42nd Annual Health Care Conference". Philadeliphia, PA & Oxford. |
2017-05-02 |
| Adaptimmune Therapeutics plc. (5/16/17). "Press Release: Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting MAGE-A4 in Multiple Solid Tumors". Philadeliphia, PA & Oxford. |
2017-05-16 |
| Adaptimmune Therapeutics plc. (5/15/19). "Press Release: Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products". Philadeliphia, PA & Oxfordshire. |
2019-05-15 |
| Adaptimmune Therapeutics plc. (5/10/17). "Press Release: Adaptimmune Reports First Quarter 2017 Financial Results". Philadeliphia, PA & Oxford. |
2017-05-10 |
| Adaptimmune Therapeutics plc. (5/10/17). "Press Release: Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting AFP in Liver Cancer". Philadeliphia, PA & Oxford. |
2017-05-10 |
| Adaptimmune Therapeutics plc. (4/5/17). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford. |
2017-04-05 |
| Adaptimmune Therapeutics plc. (4/16/18). "Press Release: Adaptimmune Presents MAGE-A4 and MAGE-A10 Pre-clinical Data at American Association for Cancer Research (AACR) Annual Meeting". Philadeliphia, PA & Oxford. |
2018-04-16 |
| Adaptimmune Therapeutics plc. (4/12/18). "Press Release: Adaptimmune Announces Changes to Board of Directors". Philadeliphia, PA & Oxford. |
2018-04-12 |
| Adaptimmune Therapeutics plc. (4/10/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering". Philadeliphia, PA & Oxford. |
2017-04-10 |
| Adaptimmune Therapeutics plc. (3/6/23). "Press Release: Adaptimmune and TCR2 Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors". Philadeliphia, PA, Oxford & Canbridge, MA. |
2023-03-06 |
| Adaptimmune Therapeutics plc. (3/27/17). "Press Release: Adaptimmune to Participate in Upcoming Jefferies Immuno-Oncology Summit". Philadeliphia, PA & Oxford. |
2017-03-27 |
| Adaptimmune Therapeutics plc. (3/27/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares". Philadeliphia, PA & Oxford. |
2017-03-27 |
| Adaptimmune Therapeutics plc. (3/22/17). "Press Release: Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford. |
2017-03-22 |
| Adaptimmune Therapeutics plc. (3/21/17). "Press Release: Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford. |
2017-03-21 |
| Adaptimmune Therapeutics plc. (3/2/17). "Press Release: Adaptimmune to Present at the Cowen and Company 37th Annual Health Care Conference". Philadeliphia, PA & Oxford. |
2017-03-02 |
| Adaptimmune Therapeutics plc. (3/15/17). "Press Release: Adaptimmune Broadens Executive Team". Philadeliphia, PA & Oxford. |
2017-03-15 |
| Adaptimmune Therapeutics plc. (3/13/17). "Press Release: Adaptimmune Reports Fourth Quarter and Full Year 2016 Financial Results". Philadeliphia, PA & Oxford. |
2017-03-13 |
| Adaptimmune Therapeutics plc. (3/1/17). "Press Release: Adaptimmune Cuts Ribbon on U.S. Headquarters at the Navy Yard in Philadelphia". Philadeliphia, PA & Oxford. |
2017-03-01 |
| Adaptimmune Therapeutics plc. (2/27/19). "Press Release: CORRECTING and REPLACING -- Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update". Philadeliphia, PA & Oxford. |
2019-02-27 |
| Adaptimmune Therapeutics plc. (11/8/22). "Press Release: Adaptimmune Reports Third-Quarter Financial Results and Business Update". Philadelphia, PA & Oxford. |
2022-11-08 |
| Adaptimmune Therapeutics plc. (10/25/22). "Press Release: Adaptimmune Enhances Its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK". Philadelphia, PA & Oxford. |
2022-10-25 |
| Adaptimmune Therapeutics plc. (10/23/17). "Press Release: Sébastien Desprez Joins Adaptimmune as Vice President of Communications and Investor Relations". Philadeliphia, PA & Oxford. |
2017-10-23 |
| Adaptimmune Therapeutics plc. (1/8/18). "Press Release: Adaptimmune Announces Two Manufacturing Achievements on Its Way to Become the First Fully Integrated TCR T-cell Therapy Company". Philadeliphia, PA & Oxford. |
2018-01-08 |
| Adaptimmune Therapeutics plc. (1/8/18). "Press Release: Adaptimmune Announces Positive Safety Data from Pilot Studies with MAGE-A10 SPEAR T-cells and First Patient to Receive 1 Billion Target Cell Dose". Philadeliphia, PA & Oxford. |
2018-01-08 |
| Adaptimmune Therapeutics plc. (1/4/18). "Press Release: Paul Stead Joins Adaptimmune as Vice President of Business Development". Philadeliphia, PA & Oxford. |
2018-01-04 |
| Adaptimmune Therapeutics plc. (1/14/20). "Press Release: Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies". Tokyo, Philadelphia, PA & Oxfordshire. |
2020-01-14 |
| Adaptimmune Ltd.. (9/30/19). "Press Release: Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO". Philadeliphia, PA & Oxfordshire. |
2019-09-30 |
| Adaptimmune Ltd.. (10/5/19). "Press Release: United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4". Philadeliphia, PA & Oxfordshire. |
2019-10-05 |
| Adaptimmune Ltd.. (10/1/19). "Press Release: Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer". Philadeliphia, PA & Oxfordshire. |
2019-10-01 |
| Actimed Therapeutics Ltd.. (4/5/18). "Press Release: Actimed Therapeutics Appoints Pharma Veteran Dr David Ebsworth as Chairman". Ascot. |
2018-04-05 |
| Actimed Therapeutics Ltd.. (4/2/20). "Press Release: Actimed Therapeutics Appoints Annalisa Jenkins as Advisor". London. |
2020-04-02 |
| Actimed Therapeutics Ltd.. (10/31/18). "Press Release: Actimed Therapeutics, the Cachexia Company, Raises £1.25m in Seed A Round". Ascot. |
2018-10-31 |
| Actimed Therapeutics Ltd.. (10/30/19). "Press Release: Actimed Therapeutics Appoints Robin Bhattacherjee as CEO". Ascot. |
2019-10-30 |
| Actimed Therapeutics Ltd.. (1/4/23). "Press Release: Actimed Therapeutics Successfully Closes Second Tranche of £10m Seed Financing". London. |
2023-01-04 |
| Achilles Therapeutics plc. (4/6/21). "Press Release: Achilles Therapeutics Announces Closing of $175.5 Million Initial Public Offering". London. |
2021-04-06 |
| Achilles Therapeutics plc. (3/30/21). "Press Release: Achilles Therapeutics Announces Pricing of Initial Public Offering". London. |
2021-03-30 |
| Achilles Therapeutics plc. (3/1/21). "Press Release: Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States". London. |
2021-03-01 |
| Achilles Therapeutics Ltd.. (9/3/19). "Press Release: Achilles Therapeutics Raises £100 Million in Oversubscribed Series B Financing". Stevenage. |
2019-09-03 |
| Achilles Therapeutics Ltd.. (9/19/18). "Press Release: Achilles Today Announces that It has Appointed Senior Pharmaceutical Executive Michael F. Giordano, M.D., to Its Board of Directors". Stevenage. |
2018-09-19 |
| Achilles Therapeutics Ltd.. (12/7/20). "Press Release: Achilles Therapeutics Appoints Lee M. Stern as VP, IR & External Communications". Stevenage. |
2020-12-07 |
| Achilles Therapeutics Ltd.. (12/10/18). "Press Release: Achilles Therapeutics Appoints Dr Edwin Moses as Chairman of Its Board of Directors and Dr Iraj Ali as Chief Executive Officer". Stevenage. |
2018-12-10 |
| Achilles Therapeutics Ltd.. (12/1/20). "Press Release: Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer". Stevenage. |
2020-12-01 |
| Achilles Therapeutics Ltd.. (11/19/20). "Press Release: Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours". Stevenage. |
2020-11-19 |
| Achilles Therapeutics Ltd.. (10/21/19). "Press Release: Achilles Therapeutics Appoints Beverley Carr as Chief Business Officer". Stevenage. |
2019-10-21 |
| Accession Therapeutics Ltd.. (9/20/21). "Press Release: Bent Jakobsen Starts Novel Immune-oncology Firm Accession Therapeutics, Primavera Venture Partners and Birk Venture among First Investors". Oxford. |
2021-09-20 |
| Accession Therapeutics Ltd.. (7/19/23). "Press Release: Chief Business Officer Appointed at Accession Therapeutics as Company Prepares for Clinical Trials". Oxford. |
2023-07-19 |
| Accession Therapeutics Ltd.. (11/21/22). "Press Release: Accession Therapeutics Raises £16.6m to Advance Potent Immunotherapies towards Clinical Trials". Oxford. |
2022-11-21 |
| Accession Therapeutics Ltd.. (1/26/22). "Press Release: Cancer Leader Professor Alan Parker Joins Accession Therapeutics. Co-inventor of Trocept platform to Guide Immuno-oncology Pipeline Growth". Oxford. |
2022-01-26 |
| Acacia Pharma Group Ltd.. (3/2/18). "Press Release: Acacia Pharma Successfully Prices Initial Global Offering at EUR 3.60 per Share Raising EUR40m [Not for US, AU, CA, JP, ZA, et al.]". Cambridge & Indianapolis, IN. |
2018-03-02 |
| Acacia Pharma Group Ltd.. (2/5/18). "Press Release: Acacia Pharma Announces Its Intention to Launch an Initial Global Offering and to List Its Shares on Euronext Brussels [Not for US, AU, CA, JP, ZA, et al.]". Cambridge & Indianapolis, IN. |
2018-02-05 |
| AC Immune S.A.. (9/17/19). "Press Release: AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620". Lausanne. |
2019-09-17 |
| Abzena plc. (9/19/17). "Press Release: Abzena Appoints Lotta Ljungqvist as Non-Executive Director". Cambridge. |
2017-09-19 |
| Abzena plc. (9/14/17). "Press Release: Trading Update". Cambridge. |
2017-09-14 |
| Abzena plc. (8/16/18). "Press Release: Update on Partial Monetisation of Abzena Inside Portfolio". Cambridge. |
2018-08-16 |
| Abzena plc. (8/16/18). "Press Release: Recommended Cash Offer for Abzena plc [NOT FOR RELEASE WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION]". |
2018-08-16 |
| Abzena plc. (7/2/18). "Press Release: Abzena and Telix Sign Strategic Manufacturing and Bioconjugation Agreement". Cambridge & Melbourne. |
2018-07-02 |
| Abzena plc. (1/20/17). "Press Release: Abzena Signs New ThioBridge License Agreement". Cambridge. |
2017-01-20 |
| Abzena Ltd.. (7/28/20). "Press Release: Abzena Receives Growth Capital Investment from Newly Launched Biospring Partners". Cambridge, Bristol, PA & San Diego, CA. |
2020-07-28 |
| Abzena Ltd.. (6/6/23). "Press Release: Abzena Appoints Thomas Castellano as Chief Financial Officer". San Diego, CA. |
2023-06-06 |
| Abzena Ltd.. (3/31/22). "Press Release: Abzena Secures $65 Million in Additional Funding to Accelerate Growth and Expand Capacity". San Diego, CA. |
2022-03-31 |
| Abzena Ltd.. (2/1/22). "Press Release: Abzena Appoints Kevin Lundquist as Chief Financial Officer". Cambridge & San Diego, CA. |
2022-02-01 |
| Abzena Ltd.. (1/20/22). "Press Release: Abzena Appoints Jim Kennamer as SVP and Site Head of North Carolina". Cambridge & San Diego, CA. |
2022-01-20 |
| Ablynx N.V.. (2/7/18). "Press Release: Ablynx Announces Board Changes". Ghent. |
2018-02-07 |
| Ablynx N.V.. (1/24/18). "Press Release: Ablynx Appoints Dr Robert Friesen as Chief Scientific Officer". Ghent. |
2018-01-24 |
| Abivax S.A.. (7/25/18). "Press Release: Abivax Secures up to EUR 20m Debt Financing from Kreos Capital". Paris. |
2018-07-25 |
| Abivax S.A.. (6/25/18). "Press Release: Abivax Appoints Ian McGowan as Scientific Advisory Board Chair and Juergen Rockstroh as a New Member". Paris. |
2018-06-25 |
| Abingworth LLP. (9/15/21). "Press Release: Abingworth Strengthens Investment Team with New Appointments in the US and UK". London. |
2021-09-15 |
| Abingworth LLP. (7/9/18). "Press Release: Abingworth Raises $315m for ABV VII 12th Life Sciences Fund". London. |
2018-07-09 |
| Abingworth LLP. (5/10/21). "Press Release: Abingworth Raises $582 Million for New Clinical Co-Development Fund – ACCD 2". London. |
2021-05-10 |
| Abingworth LLP. (2/3/21). "Press Release: Abingworth Raises $465m for New Life Sciences Fund Abingworth Bioventures 8". London. |
2021-02-03 |
| Abingdon Health Ltd.. (10/16/17). "Press Release: Abingdon Health and Skannex Sign a Co-marketing Agreement". |
2017-10-16 |
| Aber Instruments. (3/22/21). "Press Release: Aber Introduces Futura neotf On-line Single-use Biomass Sensor". Aberystwyth. |
2021-03-22 |
| Aber Instruments. (2/1/21). "Press Release: Aber Instruments Acquires BugLab to Consolidate its World-leading Biomass Monitoring Portfolio". Alexandria, VA. |
2021-02-01 |
| AbCellera Biologics, Inc.. (9/12/17). "Press Release: AbCellera Launches Antibody Discovery Collaboration with GSK". Vancouver, BC. |
2017-09-12 |
| AbCellera Biologics, Inc.. (11/29/18). "Press Release: AbCellera Collaborates with Autolus on Antibody Discovery Project". Vancouver, BC. |
2018-11-29 |
| Abcam plc. (8/2/21). "Press Release: Abcam to Acquire BioVision for $340 Million". Cambridge. |
2021-08-02 |
| Abcam plc. (7/2/18). "Press Release: Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research". Cambridge. |
2018-07-02 |
| Abcam plc. (6/23/23). "Press Release: Abcam Announces Review of Strategic Alternatives". Cambridge & Waltham, MA. |
2023-06-23 |
| Abcam plc. (5/18/17). "Press Release: Abcam Makes Final Performance-Based AxioMx Milestone Payment". Cambridge. |
2017-05-18 |
| Abcam plc. (4/26/18). "Press Release: Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development". Cambridge & Deqing. |
2018-04-26 |
| Abcam plc. (10/23/20). "Press Release: Abcam Announces Pricing of Offering on Nasdaq". London. |
2020-10-23 |
| Abcam plc. (10/23/20). "Press Release: Abcam Announces Launch of Offering and Application to List on the Nasdaq Global Market". London. |
2020-10-23 |
| Abcam plc. (10/23/20). "Press Release: Abcam Announces Exercise of Over-allotment Option [not for any jurisdiction where a violation of relevant laws]". London. |
2020-10-23 |
| AbbVie Inc.. (10/20/22). "Press Release: AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline". North Chicago, IL. |
2022-10-20 |
| AB Sciex (d/b/a Sciex). (9/8/17). "Press Release: Sciex Launches the Topaz LC-MS/MS System for Clinical Diagnostics in Europe". Warrington, UK. |
2017-09-08 |
| AB Sciex (d/b/a Sciex). (9/6/17). "Press Release: Sciex PA 800 Plus Continues to Deliver Quality Results for Ultimate Confidence in Biologics Characterization Data". Framingham, MA. |
2017-09-06 |
| AB Sciex (d/b/a Sciex). (9/13/17). "Press Release: Meet Sciex and Learn about Industrialized Biomarker Research Using SWATH Acquisition at HUPO 2017". Framingham, MA. |
2017-09-13 |
| AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. |
2017-07-27 |
| AAVantgarde Bio S.r.l.. (9/8/22). "Press Release: AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer". Milan. |
2022-09-08 |
| A-Mansia Biotech S.A.. (4/27/18). "Press Release: Belgian Microbiome Spin-off A-Mansia Announces €13m First Close of Series A Financing". Louvain-la-Neuve. |
2018-04-27 |
| 908 Devices, Inc.. (1/7/22). "Press Release: 908 Devices Announces GSK Purchases Fifth Rebel Cell Culture Media Analyzer". Boston, MA. |
2022-01-07 |
| 4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. |
2019-02-06 |
| 4D Pharma plc. (10/8/19). "Press Release: 4D Pharma Collaborates with MSD to Develop Live Biotherapeutics for Vaccines". |
2019-10-08 |
| 4BIO Capital (4BIO Ventures Management Ltd.). (9/9/19). "Press Release: 4BIO Capital Raises $50 million in First Close of New Advanced Therapies Fund". London & Boston, MA. |
2019-09-09 |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
Source
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
